B
Byeong Woo Park
Researcher at Yonsei University
Publications - 228
Citations - 7417
Byeong Woo Park is an academic researcher from Yonsei University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 45, co-authored 214 publications receiving 6208 citations. Previous affiliations of Byeong Woo Park include University Health System & Seoul National University.
Papers
More filters
Journal ArticleDOI
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda,Soo Jung Lee,Shoichiro Ohtani,Young-Hyuck Im,Eun Sook Lee,Isao Yokota,Katsumasa Kuroi,Seock-Ah Im,Byeong Woo Park,Sung-Bae Kim,Yasuhiro Yanagita,Shinji Ohno,Shintaro Takao,Kenjiro Aogi,Hiroji Iwata,Joon Jeong,Ae-Ree Kim,K. H. Park,Hironobu Sasano,Yasuo Ohashi,Masakazu Toi +20 more
TL;DR: After standard neoadjuvant chemotherapy containing anthracycline, taxane, or both, the addition of adjuvant capecitabine therapy was safe and effective in prolonging disease‐free survival and overall survival among patients with HER2‐negative breast cancer who had residual invasive disease on pathological testing.
Journal ArticleDOI
Expression of androgen receptors in primary breast cancer
S.H. Park,Ja Seung Koo,Hyung Seok Park,J.H. Kim,Sungyoul Choi,Jyung-Hyun Lee,Byeong Woo Park,Kyung-Eun Lee +7 more
TL;DR: AR is expressed in a significant number of breast cancers and is associated with lower tumor burden and favorable differentiation, and is significantly correlated with human epidermal growth factor receptor type 2 (HER-2) overexpression in ER-negative tumors.
Journal ArticleDOI
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.
Byeong Woo Park,Hongtao Zhang,Chuan-Jin Wu,Alan Berezov,Xin Zhang,Raj Dua,Qiang Wang,Gary D. Kao,Donald M. O'Rourke,Mark I. Greene,Ramachandran Murali +10 more
TL;DR: A structure-based derivation of the AHNP represents a novel strategy for the design of receptor-specific tumor therapies for p185HER2/neu-expressing human cancers.
Journal ArticleDOI
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
Seho Park,Ja Seung Koo,Min Suk Kim,Hyung Seok Park,Jun Sang Lee,Jong Seok Lee,Seung Il Kim,Byeong Woo Park +7 more
TL;DR: Molecular subtypes using four biomarkers could provide clinically useful information of tumor biology and clinical behaviors, and could be used for determining treatment and surveillance strategies.
Journal ArticleDOI
Up-regulation of Acetyl-CoA Carboxylase α and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells
Sarah Yoon,Min Young Lee,Sahng Wook Park,Jong Seok Moon,Yoo Kyung Koh,Yong-Ho Ahn,Byeong Woo Park,Kyung-Sup Kim +7 more
TL;DR: In this paper, the authors determined the mechanism by which FASN and acetyl-CoA carboxylase α (ACCα) could be induced by HER2 overexpression.